Clifford Sosin - CAS Investment Partners 13F Activity & Position Changes (Q1 2022)

According to the SEC 13F filed on May 16, 2022, the CAS Investment Partners portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2022, the filing reported:

New Buys - None reported
Reductions - Herbalife
Complete Exits - None reported

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2022
CDLX
Cardlytics, Inc. Common Stock
Buy
+229,650
Q1 2022
CVNA
Carvana Co.
Buy
+848,600
Q1 2022
G4412G101
Herbalife
Sell
-155,000
CAS Investment Partners 13F Activity (Q1 2022)